GlassScriptPhysician profile
John J Anderson
NPI 1235101940
$1,386,611.23
in general payments reported to CMS, 2019-2025
17 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,437 · 2020: $2,599 · 2021: $504K · 2022: $738K · 2023: $27K · 2024: $54K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $125K · Consulting Fee: $5,820 · Acquisitions: $1,304 · Travel and Lodging: $989 · Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $125,214.56 |
| Consulting Fee | $5,820.00 |
| Acquisitions | $1,303.63 |
| Travel and Lodging | $988.50 |
| Food and Beverage | $986.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $729,548.04 | 2022-2023 | Motoband |
| Trilliant Surgical LLC. | $455,835.35 | 2019-2021 | |
| Vilex LLC | $181,453.90 | 2021-2025 | Alphalok, Hintermann |
| Ortho Solutions INC | $8,345.68 | 2019-2025 | |
| Wright Medical Technology, INC. | $6,502.05 | 2019-2020 | |
| Organogenesis INC. | $2,095.15 | 2019-2021 | |
| Stryker Corporation | $1,883.72 | 2020-2024 | Inbone, Infinity Adaptis |
| Smith+Nephew, INC. | $523.69 | 2021-2025 | Stravix, Grafix, Grafix Pl |
| Encore Medical, LP | $163.87 | 2022 | |
| Orthofix Medical, INC. | $87.68 | 2019-2021 | |
| Cpm Medical Consultants, LLC | $46.69 | 2020 | |
| Integra Lifesciences Corporation | $38.62 | 2019 | |
| Djo, LLC | $35.18 | 2019 | |
| Amgen INC. | $22.96 | 2020 | |
| Abbott Laboratories | $19.66 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stability Biologics, LLC | $8.99 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$83,305.31 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.